Allergenic profile of nasal polyposis

Journal of Investigational Allergology and Clinical Immunology

Volumn 19, Issue 2, 2009, Pages 110-116

  Castillo, F Muñoz Del ^a,b,c   Jurado Ramos, A ^a,b   Fernandez Conde B L ^a,b   Soler, R ^a,b   Barasona, M J ^a   Cantillo, E ^a,b   Moreno, C ^a   Guerra, F ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c Universidad de Cordoba   (Spain)

Author keywords

Allergy; Chronic rhlnoslnusltls; Common airborne allergens; IgE medlated phenomena. Nasal polyposis. Olea europaea

Indexed keywords

ALLERGEN; HOUSE DUST ALLERGEN; POLLEN ANTIGEN;

ADULT; AGED; ALLERGIC ASTHMA; ALLERGY; ALLERGY TEST; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; OLIVE TREE; PRICK TEST; WEATHER;

ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ANTIGENS, PLANT; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; OLEA; RESPIRATORY HYPERSENSITIVITY; RHINITIS; SKIN TESTS;

EID: 65249124076     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Pang YT, Eskici O, Wilson JA. Nasal polyposis: Role of subclinical delayed food hypersensitivity. Otolaryngol Head Neck Surgery. 2000;122:298-301.
2. Asero R, Bottazi G. Hypersensitivity to molds in patients with nasal polyposis: A clinical study. J Allergy Clin Immunol. 2000;105:186-8.
3. Stammberger H. Examination and endoscopy of the nose and paranasal sinuses. In Mygind N, Lildholt T, eds. Nasal polyposis: An inflammatory disease and its treatment. Munksgaard. 1977;120-36.
4. Molnar-Gabor E, Endreffy E, Rozsari A. HLA-DRB1, DQA1 and DQB1 genotypes in patients with nasal polyposis. Laryngoscope. 2000;110:422-5.
5. Settipane GA. Nasal polyps: Pathology, immunology and treatment. Am J Rhinol. 1987;1:119-26.
6. Drake-Lee AB, Price J. Mast cell ultrastructure in the inferior turbinate and stroma of nasal polyps. J Laryngol Otol. 1997;111(4):340-5.
7. Soler R, Juliá MR, Tolosa F. Estudio clínico- inmunológico de 36 casos de poliposis nasal. Rev. Esp. Alerg Immunol Clin.1987;2:287.
8. Slavin RG. Nasal polyps and sinusitis. In: Middleton E. Allergy Principles and practice. Mosby 5th ed. 1999;72:1024-33.
9. Salari H, Borgeat P, Steend P. Immunological release of leukotrienes and histamine from nasal polyps. Clin Exp Immunol. 1986;63:711-717.
10. Scavuzzo MC, Fattorl B, Ruffoli R, Rocchi V,Carpi A, Berni R, Giambelluca MA, Giannessl F. Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis. Blomed Pharmacother. 2005;59:323-9.
11. Lee CH, Rhee CS, Min YG. Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol. 1998;107:665-70.
12. Bachert C. Comparison between polyp tissue, diseased sinus mucosa and normal tissue. In Mygind N, Lildholdt T, Eds. Nasal polyposis: An inflammatory disease and its treatment. Munksgaard. 1997:98-104.
13. Tingsgaard PK, Bock T, Larsen PL. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (VCAM-1 and P-selectin) and eosinophil infiltration in nasal polyps. Acta Otolaryngol Stockh. 1999;119:362-8.
14. Caplin I, Haynes TJ, Spahn J. Are nasal polyps an allergic phenomenon? Ann Allergy. 1971;29:63-8.
15. Drake-Lee AB. Nasal polyps. In Mackay IS ed. Rhinitis: Mechanisms and management. London: Royal Society of Medicine, 1989:141-52.
16. Pumhirum P, Limitlaohapanth C, Wasuwat P. Role of allergy in nasal polyps of Thai patients. Asian Pac J Allergy Immunol. 1999;17:13-5.
17. Cheng W, Zheng C, Tian J, Shi G. T helper cell population and eosinophilia in nasal polyps. J Investig Allergol Clin Immunol. 2007;Vol. 17:297-301.
18. Ponikau H, Sherris D, Kern E, Homburger H, Frigas E, Gaffey T, Roberts G. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clinic Proc. 1999;74:877-84.
19. Catten M, Murr A, Golstein J, Mhatre A, Lalwani A. Detection of fungi in the nasal mucosa using polymerase chain reaction. Laryngoscope. 2001;111:399-402.
20. Bachert C, Gevaert P, Holtappels G, Van Cauwenberge P. Mediators in nasal polyposis. Curr Allergy Asthma Rep. 2002;2(6):481-7.
21. Schubert MS. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis and related disorders. Ann Allergy Asthma Immunol. 2001;87:181-8.
22. Bucholtz GA, Salzman SA, Bersalona FB, Boyle T, EjercitoV, Penno L, Petersson D, Stone G, Urquhart A, Shukla S, Burmester J. PCR analysis of nasal polyps, chronic sinusitis and hypertrophied turbinates for DNA encoding bacterial 16S rRNA. Am J Rhino 2002;16(3):169-73.
23. Fokkens W, Lund V, Mullol J. On behalf of the European Position Paper on Rhinosinusitis and Nasal Polyp Group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology. 2007;Suppl 20:1-136.
24. Naclerio RM. Clinical manifestations of the release of histamine and other inflammatory mediators. J Allergy Clin Immunol. 1999;103:382-5.
25. Pawliczak R, Kowalski ML, Danilewicz M, Wagrowska- Danilewicz M, Lewandowski A. Distribution of mast cells and eosinophils in nasal polyps from atopic and non-atopic subjects: a morphometric study. Am J Rhlnol. 1997;1 1(4):257-62.
26. Maloney JR. Nasal polyps, nasal polypectomy, asthma and aspirin sensitivity. J Laryngol Otol. 1977;91:837-46.
27. Mygind N, Dahl R, Bachert Cl. Nasal polyposis, eosinophil dominated inflammation and allergy. Thorax. 2000;55:579-83.
28. Drake-Lee AB, Bickerton R, McLaughlan P. Free histamine in nasal polyps fluid. Rhlnology. 1984;22:133-8.
29. Drake-Lee AB, McLaughlan P. Clinical symptoms, free histamine and IgE in patients with nasal polyposis. Int Arch Allergy Immunol. 1982;69:268-71.
30. Bernstein JM, Cropp GA, Nathanson I. Bioelectric properties of cultured nasal polyps and turbinate epithelial cells. Am J Rhlnol. 1990;4:45-9.
31. Bernstein JM, Yankaskas JR. Increased ion transport in cultured nasal polyps epithelial cells. Arch Otolaryngol Head Neck Surg. 1994;120:993-6.
32. Bachert C, Gevaert P, Holtappels G, Johansson SGO, Van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107(4):607-14.
33. Klossek JM, Neukirch F, Pribil C, Jankowski R, Serrano E, Chanal I, El-Hasnaoui A. Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy. 2005;60:233-7.
34. Collins M, Nair S, Smith W, Kette F, Gillis D, Wormald PJ. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope. 2004;114(7):1242-6.
35. Settipane GA, Chafee E. Nasal polyps in asthma and rhinitis: A review of 6037 patients. J Allergy Clin Immunol. 1977;59:17-21.
36. Alobid I, Benítez P, Valero A, Berenguer J, Bernal-Sprekelsen M, Picado C, Mullol J. The impact of atopy, sinus opacification, and nasal patency on quality of life in patients with severe nasal polyposis. Otolaryngol Head Neck Surg. 2006;134(4):609-12.
37. Bernstein J, Gorfien J, Noble BR. Role of allergy in nasal polyposis: A review. Otolaryngol Head Neck Surg. 1995;113:724-32.
38. Keith PK, Conway M, Evans S, Wong DA, Jordana G, Pengelly D, Dolovlch J. Nasal polyps: Effects of seasonal allergen exposure. J Allergy Clin Immunol. 1994;93(3):567-74.
39. Park HS, Kim HY, Nahm DH, Park K, Suh KS, Yim H. The presence of atopy does not determine the type of cellular infiltrate in nasal polyps. Allergy Asthma Proc. 1998;19 (6):373-7.
40. Klossek J, Dufour X, Desmonts C, Fontanel J. Asthme et polypose. Allerg Immunol. 1998;30(3):69-72.
41. King WP. Food hypersensitivity in otolaryngology. Otolaryngol Clin North Am. 1992;25:163-79.
42. Demoly P, Bencherioua A, Crampette L, Dhivert-Donnadieu H, Godard P, Michel F. From allergic rhinitis to sinus diseases (sinusitis/nasal polyps): epidemiologic and experimental links. Rev Mal Respir. 2000;17(5):925-30.
43. Stroud R, Calhoun K, Wright S, Kennedy, K. Prevalence of hypersensitivity to specific fungal allergens as determined by intradermal dilutional testing. Otolaryngol Head Neck Surg. 2001;125:491-4.
44. Guerra F, Moreno C, Daza JC, Miguel R, García M, Sánchez Guijo P. Linear monitoring of patients sensitive to Olea and grass pollens treated with immunotherapy based on glutaraldehyde-modified (allergoid) extracts. J Investig Allergol Clin Immunol. 1993;3(4):182-90.
45. Guerra F, Moreno C, Daza JC, García M, Arenas A, Miguel R, Sánchez Guijo P. IgG4 levels in relation to Olea europaea immunotherapy. J Investlg Allergol Clin Immunol. 1992;2(6):307-12.
46. Llccardl G,; Russo M, Piccolo A, Lobefalo G, Salzlllo A, D'Amato M, D'Amato G. The perennial pattern of clinical symptoms in children monosensitized to Olea europea pollen allergens in comparison with subjects with Parietaria and Gramineae pollinosls. Allergy Asthma Proc. 1997;18(2):99-105.
47. Liccardi G, D'Amato M, D'Amato G. Oleaceae pollinosis: a review. Int Arch Allergy Immunol. 1996;111(3):210-7.
48. Guerra F, Daza JC, Almeda E. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment. J Investig Allergol Clin Immunol. 2003;13(2):108-17.
49. Domínguez E, Infante F, García-Pantaleón F, Galán C; Guerra F; Villamandos F. Variations in the concentrations of airborne Olea pollen and associated pollinosis in Córdoba (Spain); a study of the ten years period 1982-1991. J Investig Allergol Clin Immunol. 1993;3(6):294-9.